Meta-Analysis: Depot Medroxyprogesterone Acetate Linked to Increase in HIV Acquisition (FREE)
By Amy Orciari Herman
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
A new meta-analysis adds to evidence suggesting that depot medroxyprogesterone acetate (DMPA, marketed as Depo-Provera) is associated with increased risk for HIV acquisition. The findings appear in …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news